Certain Immunocompromised Individuals Can Receive a Third COVID-19 Vaccination

The U.S. FDA amended its emergency Authorizations for both the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty) and the Moderna COVID-19 Vaccine (SpikeVax) on August 12, 2021, to allow for the use of an additional dose in certain immunocompromised individuals.

This FDA Authorization specifically benefits solid organ transplant recipients or those diagnosed with conditions considered to have an equivalent level of immunocompromise.

However, this FDA action does not apply to people who are not immunocompromised.